Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Chen

Showing results (211-220 of 311) with videos related to

Pageof 32
Sort By:
European Journal of Cancer (Oxford, England : 1990)|December 25, 2012
Response to letter 'outcome of second-line chemotherapy for biliary tract cancer'Thomas Walter, Anne M Horgan, Mairead McNamara, et al.
European Journal of Cancer (Oxford, England : 1990)|September 6, 2012
Feasibility and benefits of second-line chemotherapy in advanced biliary tract cancer: a large retrospective studyThomas Walter, Anne M Horgan, Mairead McNamara, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 24, 2012
Sequence dependence of MEK inhibitor AZD6244 combined with gemcitabine for the treatment of biliary cancerJunyao Xu, Jennifer J Knox, Emin Ibrahimov, et al.
European Journal of Medicinal Chemistry|August 10, 2023
Structure activity relationships of 5-HT<sub>2B</sub> and 5-HT<sub>2C</sub> serotonin receptor antagonists: N<sup>6</sup>, C2 and 5'-Modified (N)-methanocarba-adenosine derivativesDilip K Tosh, Maggie M Calkins, Marko S Ivancich, et al.
Journal of Gastrointestinal Oncology|January 13, 2023
Outcomes of patients with esophageal cancer after allogeneic hematopoietic stem cell transplantationRam Vasudevan Nampoothiri, Jonathan Yeung, Andrew Pierre, et al.
Early Intervention in Psychiatry|July 26, 2021
Clinical and psychological correlates of insight dimensions in patients with early psychosisTze Kwan Kam, Tsz Ting Lui, Fu Chun Lau, et al.
Cell|July 9, 2024
A non-canonical role for a small nucleolar RNA in ribosome biogenesis and senescenceYujing Cheng, Siwen Wang, He Zhang, et al.
Journal of Gastrointestinal Cancer|August 18, 2018
Tumor Platinum Concentrations and Pathological Responses Following Cisplatin-Containing Chemotherapy in Gastric Cancer PatientsYanshuo Cao, Qing Chang, Michael Cabanero, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 10, 2008
Phase I and pharmacokinetic study of daily oral AZD2171, an inhibitor of vascular endothelial growth factor tyrosine kinases, in combination with carboplatin and paclitaxel in patients with advanced non-small-cell lung cancer: the National Cancer Institute of Canada clinical trials groupScott A Laurie, Isabelle Gauthier, Andrew Arnold, et al.
Nature Communications|September 19, 2024
PRMT1 inhibition perturbs RNA metabolism and induces DNA damage in clear cell renal cell carcinomaJoseph Walton, Angel S N Ng, Karen Arevalo, et al.
Pageof 32

Showing results (211-220 of 311) with videos related to

Sort By:
Pageof 32
European Journal of Cancer (Oxford, England : 1990)|December 25, 2012
Response to letter 'outcome of second-line chemotherapy for biliary tract cancer'Thomas Walter, Anne M Horgan, Mairead McNamara, et al.
European Journal of Cancer (Oxford, England : 1990)|September 6, 2012
Feasibility and benefits of second-line chemotherapy in advanced biliary tract cancer: a large retrospective studyThomas Walter, Anne M Horgan, Mairead McNamara, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 24, 2012
Sequence dependence of MEK inhibitor AZD6244 combined with gemcitabine for the treatment of biliary cancerJunyao Xu, Jennifer J Knox, Emin Ibrahimov, et al.
European Journal of Medicinal Chemistry|August 10, 2023
Structure activity relationships of 5-HT<sub>2B</sub> and 5-HT<sub>2C</sub> serotonin receptor antagonists: N<sup>6</sup>, C2 and 5'-Modified (N)-methanocarba-adenosine derivativesDilip K Tosh, Maggie M Calkins, Marko S Ivancich, et al.
Journal of Gastrointestinal Oncology|January 13, 2023
Outcomes of patients with esophageal cancer after allogeneic hematopoietic stem cell transplantationRam Vasudevan Nampoothiri, Jonathan Yeung, Andrew Pierre, et al.
Early Intervention in Psychiatry|July 26, 2021
Clinical and psychological correlates of insight dimensions in patients with early psychosisTze Kwan Kam, Tsz Ting Lui, Fu Chun Lau, et al.
Cell|July 9, 2024
A non-canonical role for a small nucleolar RNA in ribosome biogenesis and senescenceYujing Cheng, Siwen Wang, He Zhang, et al.
Journal of Gastrointestinal Cancer|August 18, 2018
Tumor Platinum Concentrations and Pathological Responses Following Cisplatin-Containing Chemotherapy in Gastric Cancer PatientsYanshuo Cao, Qing Chang, Michael Cabanero, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 10, 2008
Phase I and pharmacokinetic study of daily oral AZD2171, an inhibitor of vascular endothelial growth factor tyrosine kinases, in combination with carboplatin and paclitaxel in patients with advanced non-small-cell lung cancer: the National Cancer Institute of Canada clinical trials groupScott A Laurie, Isabelle Gauthier, Andrew Arnold, et al.
Nature Communications|September 19, 2024
PRMT1 inhibition perturbs RNA metabolism and induces DNA damage in clear cell renal cell carcinomaJoseph Walton, Angel S N Ng, Karen Arevalo, et al.
Pageof 32